Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H21NO |
Molecular Weight | 255.3547 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=ZZVUWRFHKOJYTH-UHFFFAOYSA-N
InChI=1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3
Molecular Formula | C17H21NO |
Molecular Weight | 255.3547 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:42:07 UTC 2023
by
admin
on
Fri Dec 15 17:42:07 UTC 2023
|
Record UNII |
8GTS82S83M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QD04AA32
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
||
|
WHO-VATC |
QR06AA52
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
||
|
WHO-VATC |
QR06AA02
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
||
|
NDF-RT |
N0000175587
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
||
|
WHO-ATC |
R06AA02
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
||
|
WHO-ATC |
R06AA52
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
||
|
LIVERTOX |
NBK548470
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
||
|
NDF-RT |
N0000000190
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
||
|
NCI_THESAURUS |
C267
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
||
|
NCI_THESAURUS |
C29578
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
||
|
WHO-ATC |
D04AA32
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8GTS82S83M
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
SUB07211MIG
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
916
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
m4609
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | Merck Index | ||
|
1774
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
100000090257
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
1224
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
CHEMBL657
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
Diphenhydramine
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
DTXSID4022949
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
3498
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | RxNorm | ||
|
200-396-7
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
3100
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
58-73-1
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
DB01075
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
DIPHENHYDRAMINE
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
D004155
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
C61728
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
4636
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
8GTS82S83M
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY | |||
|
3066
Created by
admin on Fri Dec 15 17:42:07 UTC 2023 , Edited by admin on Fri Dec 15 17:42:07 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> SUBSTRATE |
N-demethylation of diphenhydramine is mainly catalyzed by CYP2D6 as a high-affinity P450 isozyme at a clinically relevant concentration.
MAJOR
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
TARGET -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> SUBSTRATE |
CYP1A2, CYP2C9, and CYP2C19 are involved in the metabolism of diphenhydramine as low-affinity P450 isozymes.
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
METABOLIC ENZYME -> INHIBITOR |
POTENT
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> INHIBITOR | |||
|
METABOLIC ENZYME -> SUBSTRATE |
CYP1A2, CYP2C9, and CYP2C19 are involved in the metabolism of diphenhydramine as low-affinity P450 isozymes.
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> SUBSTRATE |
CYP1A2, CYP2C9, and CYP2C19 are involved in the metabolism of diphenhydramine as low-affinity P450 isozymes.
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
TRANSPORTER -> INHIBITOR | |||
|
SUBSTANCE->BASIS OF STRENGTH |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |